IIN · Intricon Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $125.21M | $102.77M | $113.49M | $68.98M | $68.01M | $67.09M |
| Cost of Revenue | $93.82M | $76.60M | $82.51M | $79.30M | $61.82M | $50.94M |
| Gross Profit | $31.39M | $26.18M | $30.99M | $37.16M | $26.49M | $17.07M |
| R&D | $5.32M | $5.25M | $3.83M | $4.67M | $4.46M | $4.69M |
| SG&A | $16.58M | $15.01M | $13.93M | $13.01M | $10.34M | $9.15M |
| Total Operating Expenses | $30.90M | $29.25M | $33.03M | $30.05M | $24.24M | $18.67M |
| D&A | $5.54M | $4.62M | $3.28M | $2.94M | $2.19M | $2.04M |
| Operating Income | $487.0K | ($3.08M) | ($2.04M) | $7.11M | $2.25M | ($1.60M) |
| Interest Expense | - | - | - | $553.0K | $369.0K | $461.0K |
| Income Tax | $135.0K | $61.0K | $201.0K | $484.0K | $8.0K | $217.0K |
| Net Income | ($106.0K) | ($2.52M) | ($3.78M) | $5.55M | $1.80M | ($4.59M) |
| EPS - Basic | ($0.01) | ($0.28) | ($0.43) | $0.73 | $0.26 | ($0.71) |
| EPS - Diluted | ($0.01) | ($0.28) | ($0.43) | $0.64 | $0.25 | ($0.71) |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.58M | $8.61M | $1.26M | $979.0K | $328.0K | $217.0K |
| Accounts Receivable | $8.26M | $10.12M | $8.99M | $11.48M | $9.05M | $7.29M |
| Inventory | $24.46M | $19.51M | $16.38M | $18.98M | $15.40M | $12.34M |
| Accounts Payable | $9.40M | $8.67M | $9.88M | $13.19M | $10.42M | $6.72M |
| Current Assets | $74.38M | $69.27M | $70.28M | $84.54M | $27.01M | $21.97M |
| Total Assets | $122.46M | $121.30M | $113.59M | $115.25M | $53.18M | $43.76M |
| Current Liabilities | $20.21M | $18.66M | $16.93M | $21.65M | $18.80M | $13.52M |
| Long-term Debt | - | - | - | $9.32M | $9.28M | $7.93M |
| Total Liabilities | $28.71M | $30.10M | $23.10M | $23.27M | $32.52M | $24.75M |
| Stockholders' Equity | $93.66M | $91.16M | $90.75M | $92.23M | $20.92M | $18.56M |
| Retained Earnings | ($6.92M) | ($6.81M) | ($4.29M) | ($509.0K) | ($6.83M) | ($8.63M) |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $438.0K | $5.62M | $1.47M | ($405.0K) | $4.23M | ($405.0K) |
| Investing Cash Flow | ($2.22M) | ($3.50M) | ($242.0K) | ($2.30M) | ($2.30M) | ($958.0K) |
| Financing Cash Flow | ($1.15M) | ($1.99M) | ($109.0K) | $3.51M | $3.53M | ($1.94M) |
| CapEx | $2.50M | $3.63M | $4.59M | $5.51M | $2.31M | $1.77M |
| Free Cash Flow | ($2.07M) | $1.99M | ($3.12M) | ($5.91M) | $1.92M | ($2.17M) |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 25.1% | 25.5% | 27.3% | 53.9% | 39.0% | 25.4% |
| Operating margin | 0.4% | -3.0% | -1.8% | 10.3% | 3.3% | -2.4% |
| EBITDA margin | 4.8% | 1.5% | 1.1% | 14.6% | 6.5% | 0.7% |
| Net margin | -0.1% | -2.5% | -3.3% | 8.0% | 2.6% | -6.8% |
| Free cash flow margin | -1.7% | 1.9% | -2.8% | -8.6% | 2.8% | -3.2% |
| FCF / Net income | 19.49 | -0.79 | 0.83 | -1.07 | 1.06 | 0.47 |
| R&D / Revenue | 4.2% | 5.1% | 3.4% | 6.8% | 6.6% | 7.0% |
| SG&A / Revenue | 13.2% | 14.6% | 12.3% | 18.9% | 15.2% | 13.6% |
| Effective tax rate | 465.5% | - | - | 8.0% | 0.4% | - |
| Return on assets | -0.1% | -2.1% | -3.3% | 4.8% | 3.4% | -10.5% |
| Return on equity | -0.1% | -2.8% | -4.2% | 6.0% | 8.6% | -24.7% |
| Return on invested capital | - | - | - | 6.4% | 7.4% | -4.8% |
| Liquidity | ||||||
| Current ratio | 3.68 | 3.71 | 4.15 | 3.91 | 1.44 | 1.63 |
| Quick ratio | 2.47 | 2.67 | 3.18 | 3.03 | 0.62 | 0.71 |
| Cash ratio | 0.28 | 0.46 | 0.07 | 0.05 | 0.02 | 0.02 |
| Leverage | ||||||
| Debt / Equity | - | - | - | 0.10 | 0.44 | 0.43 |
| Debt / Assets | - | - | - | 0.08 | 0.17 | 0.18 |
| Debt / EBITDA | - | - | - | 0.93 | 2.09 | 18.06 |
| Interest coverage | - | - | - | 12.9x | 6.1x | -3.5x |
| Equity multiplier | 1.31 | 1.33 | 1.25 | 1.25 | 2.54 | 2.36 |
| Liabilities / Assets | 0.23 | 0.25 | 0.20 | 0.20 | 0.61 | 0.57 |
| Efficiency | ||||||
| Asset turnover | 1.02 | 0.85 | 1.00 | 0.60 | 1.28 | 1.53 |
| Inventory turnover | 3.84 | 3.93 | 5.04 | 4.18 | 4.02 | 4.13 |
| Days sales outstanding | 24d | 36d | 29d | 61d | 49d | 40d |
| Days inventory outstanding | 95d | 93d | 72d | 87d | 91d | 88d |
| Days payable outstanding | 37d | 41d | 44d | 61d | 62d | 48d |
| Cash conversion cycle | 83d | 88d | 58d | 87d | 78d | 80d |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 21.8% | -9.4% | 64.5% | 1.4% | 1.4% | 26.7% |
| Revenue CAGR (3y) | 22.0% | 14.8% | 19.2% | 9.2% | 4.3% | 8.8% |
| Revenue CAGR (5y) | 13.3% | 14.2% | 13.6% | 5.8% | 3.0% | 5.4% |
| Gross profit growth (YoY) | 19.9% | -15.5% | -16.6% | 40.3% | 55.2% | -10.2% |
| Operating income growth (YoY) | - | -50.7% | - | 216.6% | - | - |
| Net income growth (YoY) | 95.8% | 33.2% | - | 207.8% | - | - |
| EPS growth (YoY) | 96.4% | 34.9% | - | 156.0% | - | - |
| EPS CAGR (3y) | - | - | - | 21.1% | -12.3% | - |
| EPS CAGR (5y) | - | - | - | - | 15.8% | - |
| FCF growth (YoY) | - | - | 47.2% | - | - | 33.6% |
| FCF CAGR (5y) | - | - | - | - | 47.8% | - |
| Book value growth (YoY) | 2.7% | 0.5% | -1.6% | 340.9% | 12.7% | -1.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$119.85M totalDiabetes$69.73M · 58.2%
Interventional Catheters$14.57M · 12.2%
Hearing Health Legacy Oem$10.85M · 9.1%
Medical Biotelemetry Other$8.72M · 7.3%
Hearing Health Value Based ITEC$8.05M · 6.7%
Professional Audio Communications$4.44M · 3.7%
Hearing Health Value Based DTEC$3.48M · 2.9%
Geographic
$125.21M totalUS$92.92M · 74.2%
All Other Countries$13.17M · 10.5%
Asia$12.55M · 10.0%
Europe$6.56M · 5.2%
Stability scores
Altman Z′
FY 2021 · bankruptcy risk
2.67
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2021 · 9-point quality
4/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Electronic Components & Accessories
Comparing INTRICON CORP against the 5 most active filers in the same SIC group.